LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
83.90
+0.85 (1.02%)
At close: Mar 31, 2025, 4:00 PM
84.80
+0.90 (1.07%)
Pre-market: Apr 1, 2025, 4:27 AM EDT
LeMaitre Vascular Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LeMaitre Vascular stock have an average target of 97, with a low estimate of 75 and a high estimate of 110. The average target predicts an increase of 15.61% from the current stock price of 83.90.
Analyst Consensus: Buy
* Price targets were last updated on Feb 28, 2025.
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 4 | 4 |
| Buy | 2 | 3 | 3 | 3 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +31.11% | Feb 28, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +31.11% | Feb 28, 2025 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 28, 2025 |
| Wells Fargo | Wells Fargo | Hold Initiates $95 | Hold | Initiates | $95 | +13.23% | Feb 13, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $90 → $93 | Buy | Reiterates | $90 → $93 | +10.85% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
244.04M
from 219.86M
Increased by 11.00%
Revenue Next Year
264.73M
from 244.04M
Increased by 8.48%
EPS This Year
2.28
from 1.93
Increased by 18.23%
EPS Next Year
2.52
from 2.28
Increased by 10.45%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 256.3M | 284.6M | 314.0M | ||
| Avg | 244.0M | 264.7M | 288.7M | ||
| Low | 231.0M | 243.0M | 264.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.6% | 16.6% | 18.6% | ||
| Avg | 11.0% | 8.5% | 9.1% | ||
| Low | 5.1% | -0.4% | -0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.42 | 2.75 | 3.09 | ||
| Avg | 2.28 | 2.52 | 2.77 | ||
| Low | 2.13 | 2.26 | 2.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.1% | 20.6% | 22.5% | ||
| Avg | 18.2% | 10.5% | 10.1% | ||
| Low | 10.2% | -0.8% | 1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.